Robert Mischler

Learn More
BACKGROUND In 1999, avian influenza A/Hong Kong/1073/99 (H9N2) virus emerged as a pandemic threat to human beings. We aimed to assess safety, tolerability, and antigenicity of whole virus and subunit H9N2 vaccines in healthy volunteers. METHODS In a phase I randomised trial we randomly assigned 60 participants to whole virus or subunit H9N2 vaccine. Two(More)
The safety and immunogenicity of a new virosome influenza vaccine was compared to commercial whole-virus vaccine and subunit vaccine in elderly people. The virosome vaccine was made by extracting the haemagglutinin from influenza virus and incorporating it into the membrane of liposomes composed of phosphatidylcholine (PC) and phosphatidylethanolamine (PE).(More)
Introduction The Rodale Institute (Kutztown, PA) began experimenting with an Organic No–Till Plus system in 2004, where commercial crops (corn, soybean, pumpkin) were no-till drilled or planted into cover crops that were rolled with a roller/crimper. The roller consists of a large steel cylinder (10.5 ft. wide x 16 in. diameter) filled with water to provide(More)
  • 1